These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement. Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822 [TBL] [Abstract][Full Text] [Related]
5. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554 [TBL] [Abstract][Full Text] [Related]
6. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures. Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515 [TBL] [Abstract][Full Text] [Related]